US 2012/0059033 A1 · Crystalline Salts of a Potent HCV Inhibitor

Abstract

This invention relates to novel tris(hydroxymethyl)aminomethane, choline and N-methyl-D-glucamine salt forms of the following Compound (1) and methods for the preparation thereof, pharmaceutical compositions thereof, and their use in the treatment of Hepatitis C Viral (HCV) infection:

Claims30

Dependent claims

A crystalline tromethamine salt of the compound of the following formula (1):

Dependencies are inferred from the claim text.

Facts

Application

13/044,027Filed 9 Mar 2011

Priority

11 Mar 2010

Published

8 Mar 2012

Term ends

Not estimatedThe source records don’t support an estimate.

Classification11 codes

C07D 417/14
Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms,…
A61P 1/16
Drugs for disorders of the alimentary tract or the digestive system: for liver or gallbladder disorders, e.g. hepatoprotective agents,…
A61P 31/12
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics: antivirals
A61P 31/14
Antivirals: for RNA viruses

Abstract

Claims30

Dependent claims

A crystalline tromethamine salt of the compound of the following formula (1):

Dependencies are inferred from the claim text.

Crystalline Salts of a Potent HCV Inhibitor

Life of this patent

Abstract

Claims30

Crystalline Salts of a Potent HCV Inhibitor

Life of this patent

Abstract

Claims30